Commonwealth Of Virginia State Board Of Health

The Commonwealth of Virginia State Board of Health Office of Epidemiology Division, operating as the Office of Epidemiology-Central Office, is a U.S. state government entity headquartered in Richmond, Virginia that provides specialized epidemiological and public health surveillance services to the federal government through both contract and grant awards. The organization is registered in SAM.gov and maintains federal eligibility to receive awards as a state government entity. Through its federal partnerships, the Office of Epidemiology-Central Office serves as a critical component of Virginia's public health infrastructure, delivering disease surveillance, monitoring, prevention, and laboratory services that support federal health agencies' missions.

The entity has demonstrated contract expertise through its provision of specialized biomedical specimens and services to the National Institute of Mental Health (NIMH). Specifically, the organization was awarded a $357,389 firm fixed price purchase order contract by NIMH in September 2022 to provide donor human brain specimens and peripheral services supporting NIMH's Human Brain Collection Core research into neurological and psychiatric disorders. Under this contract, which carried an ultimate completion date of September 29, 2025, the organization was responsible for acquiring postmortem brain and tissue samples from both psychiatrically healthy and afflicted individuals within 24-48 hours of death and transporting specimens within 24 hours to meet rigorous research requirements. This contract represented a specialized niche capability, with no small business set-aside designation applied.

The Office of Epidemiology-Central Office has been substantially more active in the federal grant space, serving as a prime awardee on multiple cooperative agreements and project grants across several federal agencies and disease surveillance domains. The organization has received cooperative agreement funding from the Centers for Disease Control and Prevention (CDC) for HIV/AIDS surveillance and monitoring, including a $664,068 award effective June 1, 2025 through September 29, 2030 under the HIV/AIDS Surveillance program (CFDA 93.944) to conduct comprehensive HIV incidence and prevalence monitoring, track risk behaviors, and inform prevention efforts through data collection and targeted testing. Additional CDC-funded cooperative agreements support tuberculosis elimination and laboratory capacity under CDC-RFA-PS-25-0003, epidemiology and laboratory capacity for emerging infectious diseases prevention under CDC-RFA-CK24-0002, viral hepatitis surveillance and prevention under PS21-2103, and national HIV behavioral surveillance in the Virginia Beach-Norfolk-Newport News metropolitan statistical area. The organization received a $291,000 Environmental Protection Agency (EPA) project grant under the Beach Monitoring and Notification Program Implementation Grants (CFDA 66.472) awarded December 1, 2024, focused on reducing waterborne illness risk through weekly water quality sampling at Virginia's coastal recreational waters, with prior EPA awards for identical purposes dated December 2023, December 2022, and December 2021. Additional project grants support childhood lead poisoning prevention under CDC-RFA-EH21-2102 and Ryan White Part B supplemental funding through the Health Resources and Services Administration (HRSA) for HIV service continuity and expansion. The organization also received federal sub-grant awards as a recipient of funding from prime grantees including The Johns Hopkins University for adult immunization programming, the Department of Behavioral Health and Developmental Services for substance abuse prevention and naloxone distribution, and the Council of State and Territorial Epidemiologists for laboratory-confirmed influenza hospitalization surveillance, with additional sub-award support from the University of Virginia for nontuberculous mycobacteria reporting and epidemiological analysis.